Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
The Smith & Nephew plc ADR price is unchanged compared to yesterday.
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | 0.000% | -7.857% | -3.008% | -16.774% | -7.857% | 0.781% | -20.370% |
| Smith & Nephew plc | 1.550% | -0.758% | -3.676% | -15.429% | -7.844% | -0.114% | -20.268% |
| Steris Corp. | -0.290% | 2.178% | 12.602% | -1.714% | -5.321% | -0.290% | 11.809% |
| Humana Inc. | -2.380% | 3.185% | -5.814% | 40.931% | 47.541% | -28.176% | -8.758% |
Comments
Smith & Nephew SNATS (SNN) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) had its "buy" rating reaffirmed by The Goldman Sachs Group, Inc..
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for SNN provided by MarketBeat